Skip to content

Incidence of post COVID-19 interstitial lung disease and impacts on lung function and quality of life

Incidence of post COVID-19 interstitial lung disease and impacts on lung function and quality of life

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220419013
Enrollment
116
Registered
2022-04-19
Start date
2022-04-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-COVID-19 interstitial lung disease Post-COVID-19 interstitial lung disease Post-COVID-19 ILD

Interventions

HRCT abnormalities which indicate the presence of ILD,No evidence of ILD on HRCT
Diagnostic,Diagnostic
Post-COVID-19 interstitial lung disease,No post-COVID-19 interstitial lung disease

Sponsors

Routine to Research (R2R) Project, Faculty of Medicine Siriraj Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age more than or equal to 18 years 2. Confirm diagnosis of COVID-19 infection by RT-PCR of respiratory specimens 3. Confirm diagnosis of pneumonia 4. Hospitalized in Siriraj Hospital (general wards and critical care units) 5. Persistent respiratory symptom after 6 months of date of symptom with abnormal chest X-ray

Exclusion criteria

Exclusion criteria: 1. Pre-existing chronic lung diseases, including interstitial lung disease and bronchiectasis 2. Pregnant woman 3. No persistent respiratory symptom after 6 months of date of symptom 4. Normal chest X-ray after 6 months of date of symptom 5. Unable to perform high resolution computed tomography 6. Unable to perform pulmonary function tests 7. Presence of contraindication for pulmonary function tests 8. Deny to enroll

Design outcomes

Primary

MeasureTime frame
Incidence of post-COVID-19 interstitial lung disease 6 months after date of symptoms Medical record and HRCT official report

Secondary

MeasureTime frame
Pulmonary function tests and associated factor of severity of impairment 6 months after date of symptoms Official report of pulmonary function tests,Quality of life and associated factor of severity of impairment 6 months after date of symptoms Questionaire (EQ-5D-5L and SGRQ),Changes of HRCT abnormalities 6 months after date of symptoms HRCT official report and radiologist consultation

Countries

Thailand

Contacts

Public ContactSupparerk Disayabutr

Faculty of Medicine Siriraj Hospital, Mahidol University

supparearg@gmail.com66851595929

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026